v3.24.1
Equity
12 Months Ended
Dec. 31, 2023
Text block [abstract]  
Equity
24.
EQUITY
 
  a.
Share capital
Ordinary shares
 
   
December 31
 
   
2022
   
2023
 
Numbers of shares authorized (in thousands)
    5,500,000       5,500,000  
 
 
 
   
 
 
 
Numbers of shares reserved (in thousands)
   
Employee share options
    400,000       400,000  
 
 
 
   
 
 
 
Number of shares issued and fully paid (in thousands)
    4,367,984       4,385,465  
 
 
 
   
 
 
 
 
   
December 31
 
   
2022
   
2023
 
   
NT$
   
NT$
   
US$ (Note 4)
 
Share capital authorized
  $  55,000,000     $  55,000,000     $  1,796,212  
 
 
 
   
 
 
   
 
 
 
Share capital reserved
     
Employee share options
  $ 4,000,000     $ 4,000,000     $ 130,634  
 
 
 
   
 
 
   
 
 
 
American Depositary Receipts
The Company’s ADS represents 2 ordinary shares of the Company. As of both December 31, 2022 and 2023, 157,164 thousand ADSs were outstanding and represented approximately 314,328 thousand ordinary shares of the Company.
 
  b.
Capital surplus
 
   
December 31
 
   
2022
   
2023
 
   
NT$
   
NT$
   
US$ (Note 4)
 
May be used to offset a deficit,
 
distributed as
cash dividends,
 
or transferred to share capital (1)
     
Issuance of ordinary shares
  $ 15,072,129     $ 15,737,752     $ 513,970  
Merger by share exchange
    117,693,658       117,693,658       3,843,686  
Difference between consideration and the carrying amount of the subsidiaries’ net assets during actual disposal or acquisition
    3,240,987       3,240,987       105,845  
Exercised employee share options
    2,943,447       3,503,786       114,428  
Treasury share transactions
    38,404       679,791       22,201  
Donations from shareholders
    471,894       471,894       15,411  
Expired share options
    646,447       646,773       21,122  
 
 
 
   
 
 
   
 
 
 
    140,106,966       141,974,641        4,636,663  
 
 
 
   
 
 
   
 
 
 
 
   
December 31
 
   
2022
   
2023
 
   
NT$
   
NT$
   
US$ (Note 4)
 
May be used to offset a deficit only
     
Changes in percentage of ownership interest in subsidiaries (2)
  $ 117,537     $ 208,310     $ 6,803  
Share of changes in capital surplus of associates accounted for using the equity method
    18,329       21,584       705  
Dividends that the claim period has elapsed and unclaimed by shareholders
    6,043       6,130       200  
Exercised disgorgement
    326       326       11  
 
 
 
   
 
 
   
 
 
 
    142,235       236,350       7,719  
 
 
 
   
 
 
   
 
 
 
May not be used for any purpose
     
Employee share options
    1,425,171       1,904,176       62,187  
Employee restricted stock awards
    778,387       (49,650     (1,621
Others (3)
    154,731       207,109       6,764  
 
 
 
   
 
 
   
 
 
 
    2,358,289       2,061,635       67,330  
 
 
 
   
 
 
   
 
 
 
  $ 142,607,490     $ 144,272,626     $  4,711,712  
 
 
 
   
 
 
   
 
 
 
 
  1)
Such capital surplus may be used to offset a deficit; in addition, when the Company has no deficit, such capital surplus may be distributed as cash dividends or transferred to share capital (limited to a certain percentage of the Company’s capital surplus and once a year).
  2)
Such capital surplus arises from the effects of changes in ownership interests in subsidiaries resulting from equity transactions other than actual disposals or acquisitions, or from changes in capital surplus of subsidiaries accounted for using the equity method.
  3)
Such capital surplus represents the excess of the carrying amount of related accounts over the par value due to employee share options exercised and the Company has not completed registration formalities.
 
  c.
Retained earnings and dividend policy
The Articles of Incorporation of the Company (the “Articles”) provides that annual net income shall be distributed in the following order:
 
  1)
Replenishment of deficits;
 
  2)
10.0% as legal reserve;
 
  3)
Special reserve appropriated or reversed in accordance with laws or regulations set forth by the authorities concerned;
 
  4)
If annual net income remains, a proposal for the distribution of such amount together with a part or all of the accumulated undistributed profits from previous years shall be prepared by the board of directors and submit to the shareholders’ meeting for resolution. However, the distributable dividends may be paid in cash after a resolution has been adopted by a majority vote at a meeting of the board of directors attended by
two-thirds
of the total number of directors; and, in addition, a report of such distribution shall be submitted to the shareholders’ meeting.
 
For the policies on the distribution of employees’ compensation and remuneration of directors, refer to employees’ compensation and remuneration of directors in Note 25(g).
The Company is currently in the mature growth stage. To meet the capital needs for business development now and in the future and satisfy the shareholders’ demand for cash inflows, the Company shall use residual dividend policy to distribute dividends, of which the cash dividend is not lower than 30% of the total dividend distribution, with the remainder to be distributed in shares. A distribution plan is also to be made by the board of directors and submitted for resolution in the shareholders’ meeting.
Appropriation of earnings to legal reserve shall be made until the legal reserve equals the Company’s share capital. Legal reserve may be used to offset deficits. If the Company has no deficit and the legal reserve has exceeded 25% of the Company’s share capital, the excess may be transferred to capital or distributed in cash.
Items referred to under Rule No. 1090150022 issued by the Financial Supervisory Commission R.O.C. and in the directive titled “Questions and Answers for Special Reserves Appropriated Following Adoption of IFRS Accounting Standards” should be appropriated to or reversed from a special reserve by the Company.
The appropriation of earnings for 2021 and 2022 were as follows:
 
   
Appropriation of Earnings
   
Dividends Per Share
 
                              
 
For Year 2021
   
For Year 2022
   
For Year 2021
   
For Year 2022
 
   
NT$
   
NT$
   
NT$
   
NT$
 
               
(in dollars)
   
(in dollars)
 
Legal reserve
  $ 6,282,762     $ 6,001,564      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Special reserve (reversed)
 
$

798,025    
$

(6,845,501    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash dividends
 
$
30,501,981    
$
38,482,083     $ 7.0     $ 8.8  
 
 
 
   
 
 
     
The above 2021 and 2022 appropriations for cash dividends were resolved by the Company’s board of directors in March 2022 and March 2023, respectively; the other proposed appropriations were resolved by the shareholders’ meeting in June 2022 and June 2023, respectively.
 
  d.
Others equity items
 
  1)
Exchange differences on translating foreign operations
 
                                                                                       
   
For the Year Ended December 31
 
   
2021
   
2022
   
2023
 
   
NT$
   
NT$
   
NT$
   
US$ (Note 4)
 
Balance at January 1
 
$
(11,641,939
 
$
(15,393,646
 
$
(5,529,388
 
$
(180,581
Recognized for the year
 
 
           
 
 
 
           
 
 
 
           
 
 
 
          
 
Exchange differences arising on translating foreign operations
 
 
(3,203,730
 
 
9,981,949
 
 
 
(1,488,920
 
 
(48,626
 
                                                                                       
   
For the Year Ended December 31
 
   
2021
   
2022
   
2023
 
   
NT$
   
NT$
   
NT$
   
US$ (Note 4)
 
Share from associates and joint ventures accounted for using the equity method
 
$
21,307
 
 
$
(117,691
 
$
(16,321
 
$
(533
 
 
 
   
 
 
   
 
 
   
 
 
 
Reclassification
 
 
           
 
 
 
           
 
 
 
           
 
 
 
          
 
Disposal of foreign operations
 
 
(569,284
 
 
— 
 
 
 
— 
 
 
 
— 
 
 
 
 
   
 
 
   
 
 
   
 
 
 
Balance at December 31
 
$
(15,393,646
 
$
(5,529,388
 
$
(7,034,629
 
$
(229,740
 
 
 
   
 
 
   
 
 
   
 
 
 
 
  2)
Unrealized gain (loss) on financial assets at FVTOCI
 
                                                                                       
   
For the Year Ended December 31
 
   
2021
   
2022
   
2023
 
   
NT$
   
NT$
   
NT$
   
US$ (Note 4)
 
Balance at January 1
 
$
2,027,902
 
 
$
4,190,361
 
 
$
1,275,505
 
 
$
41,656
 
 
 
 
   
 
 
   
 
 
   
 
 
 
Unrealized gain (loss) recognized for the year
       
Debt instruments
 
 
63,722
 
 
 
(16,746
 
 
(22,599
)
 
 
(738
)
 
Equity instruments
 
 
(8,671
 
 
(8,360
 
 
(77,496
)
 
 
(2,531
)
Share from associates and joint ventures accounted for using the equity method
 
 
3,599,703
 
 
 
(2,928,173
 
 
2,447,656
 
 
 
79,937
 
 
 
 
   
 
 
   
 
 
   
 
 
 
Other comprehensive income for the year
 
 
  3,654,754
 
 
 
(2,953,279
 
 
  2,347,561
 
 
 
    76,668
 
 
 
 
   
 
 
   
 
 
   
 
 
 
Cumulative unrealized loss of equity instruments transferred to retained earnings due to disposal
 
 
33,258
 
 
 
    190,500
 
 
 
230,940
 
 
 
7,542
 
 
   
For the Year Ended December 31
 
   
2021
   
2022
   
2023
 
   
NT$
   
NT$
   
NT$
   
US$ (Note 4)
 
Cumulative unrealized gain transferred to retained earnings due to disposal of equity instruments in relation to associates and joint venture accounted for using the equity method
  $ (1,525,553   $ (152,077   $ (304,358   $ (9,940
 
 
 
   
 
 
   
 
 
   
 
 
 
Balance at December 31
  $   4,190,361     $   1,275,505     $   3,549,648     $    115,926  
 
 
 
   
 
 
   
 
 
   
 
 
 
 
  3)
Gain (loss) on hedging instruments – hedges of net investments of foreign operations
 
   
For the Year Ended December 31
 
   
2021
   
2022
   
2023
 
   
NT$
   
NT$
   
NT$
   
US$ (Note 4)
 
Balance at January 1
  $ (429,265   $ 121,833     $ 520,281     $ 16,992  
Recognized for the year
       
Foreign currency risk – loans denominated in foreign currency
    551,098       398,448       (242,840     (7,931
 
 
 
   
 
 
   
 
 
   
 
 
 
Balance at December 31
  $     121,833     $       520,281     $     277,441     $      9,061  
 
 
 
   
 
 
   
 
 
   
 
 
 
 
  4)
Unearned employee compensation
In August 2021, the shareholders’ meeting resolved to issue restricted stock awards to employees. Refer to Note 2
8
for the information.
 
   
For the Year Ended December 31
 
   
2022
   
2023
 
   
NT$
   
NT$
   
US$ (Note 4)
 
Balance at January 1
  $ (1,164,991   $ (432,847   $ (14,136
Share-based payment expenses
        728,748       11,840       387  
Valuation adjustments
    3,396           421,007           13,749  
 
 
 
   
 
 
   
 
 
 
Balance at December 31
  $ (432,847   $ —      $ —   
 
 
 
   
 
 
   
 
 
 
 
  e.
Treasury shares
 
 
 
Purpose of Repurchase
 
 
 
Shares

Repurchased for

Cancellation
 
 
Shares

Held by

Subsidiaries
 
 
Total
 
 
 
(in thousand
shares)
 
 
(in thousand
shares)
 
 
(in thousand
shares)
 
Balance at January 31, 2022
     53,067       72,941       126,008  
Increase during the year
    1,933       —        1,933  
Decrease during the year
    (55,000     —        (55,000
 
 
 
   
 
 
   
 
 
 
Balance at December 31, 2022
    —        72,941       72,941  
 
 
 
   
 
 
   
 
 
 
Balance at December 31, 2023
    —         72,941        72,941  
 
 
 
   
 
 
   
 
 
 
In order to maintain the Company’s credit and shareholders’ rights and interests, the Company’s board of directors resolved in November 2021 to repurchase up to 55,000 thousand of the Company’s ordinary shares for cancellation at prices between NT$90 to NT$150 per share during November 8, 2021 to January 7, 2022. The Company has repurchased 55,000 thousand shares at an average price of NT$104.3. In February 2022, the Company’s board of directors resolved that February 25, 2022 was the record date for capital reduction and completed the cancellation of those repurchased ordinary shares.
In order to align with the Group’s financial strategy to simplify its investment management, ASE Test and J&R Holding reduced capital in the fourth quarter of 2022 by remitting 44,100 thousand and 23,352 thousand
ordinary
shares of the Company, respectively, to their shareholder, ASE.
The Company’s shares held by its subsidiaries at each balance sheet date were as follows:
 
    
Shares

Held by

Subsidiaries
    
Carrying

Amount
    
Carrying

Amount
    
Fair Value
    
Fair Value
 
    
(in thousand
shares)
    
NT$
    
US$
(Note 4)
    
NT$
    
US$
(Note 4)
 
December 31, 2022
              
ASE
        67,452      $ 1,762,430         $ 6,333,754     
ASE Test, Inc.
     5,489        196,677           515,454     
  
 
 
    
 
 
       
 
 
    
     72,941      $ 1,959,107         $ 6,849,208     
  
 
 
    
 
 
       
 
 
    
December 31, 2023
              
ASE
     67,452      $ 1,762,430      $ 57,558      $ 9,106,036      $ 297,389  
ASE Test, Inc.
     5,489        196,677        6,423        741,067        24,202  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
     72,941      $ 1,959,107      $ 63,981      $ 9,847,103      $ 321,591  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Fair value (Level 1) of the Company’s shares held by subsidiaries is based on the closing price from an available published price quotation.
 
Under the Securities and Exchange Act in the R.O.C., the Company shall neither pledge treasury shares nor exercise shareholders’ rights on these shares, such as the rights to dividends and voting. The subsidiaries holding the aforementioned treasury shares are bestowed shareholders’ rights except the rights to participate in any share issuance for cash and voting.
 
  f.
Non-controlling
interests
 
   
For the Year Ended December 31
 
   
2021
   
2022
   
2023
 
   
NT$
   
NT$
   
NT$
   
US$ (Note 4)
 
Balance at January 1
  $ 15,622,009     $ 14,544,415     $ 18,608,124     $ 607,711  
Share of profit for the year
    2,099,830       3,116,549       1,849,952       60,417  
Other comprehensive income (loss) for the year
       
Exchange difference on translating foreign operations
    (321,551     344,780       (47,301     (1,545
Unrealized gain (loss) on equity instruments at FVTOCI
    50,679       (44,852     26,560       867  
Gain (loss) from hedging
    187,502       110,781       (69,189     (2,260
Remeasurement on defined benefit plans
    1,497       51,582       (15,876     (518
Share in other comprehensive income (loss) from associates accounted for using the equity method
    7,902       (35,142     (7,514     (245
Subsidiaries’ buy back of their own outstanding ordinary shares (Note 31)
    (2,748,521     (312,775     —        —   
Disposal of subsidiary
    —        —        (295,895     (9,663
Non-controlling interest arising from capital increase of subsidiaries
    —        —        427,913       13,974  
Cash dividends distributed to non-controlling interests
    (1,062,529     (575,089     (912,261     (29,793
Non-controlling
interest relating to outstanding vested employee share options granted by subsidiaries
    314,398       315,871       293,740       9,593  
Equity component of convertible bonds issued by subsidiaries
    393,199       1,092,004       412,294       13,465  
 
 
 
   
 
 
   
 
 
   
 
 
 
Balance at December 31
  $  14,544,415     $  18,608,124     $  20,270,547     $    662,003